Advaxis

Advaxis

Clinical-stage biotechnology company developing immunotherapies for cancer and infectious diseases. Learn more

Launch date
Employees
Market cap
€774k
Enterprise valuation
€4m (Public information from Sep 2024)
Princeton New Jersey (HQ)
Authorizing premium user...